early postpartum women creamatocrit galactagogue prolactin inadequate breast milk volume
Conditions
Interventions
ASPNN recipe 500 mg per capsule,fine granular flour,
magnesium stearate and talcum 500 mg in the identical capsule shells
Experimental Dietary Supplement,Placebo Comparator No treatment
ASPNN,Placebo
Sponsors
Siriraj Research Development Fund (Managed by Routine to Research : R2R)
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) age of >18 years old (2) first vaginal delivery at term (3) inadequate milk volume (0-49 ml/breast pump)
Exclusion criteria
Exclusion criteria: (1) having medical disorders, such as hypertension, type 2 diabetes, thyrotoxicosis and hypothyroidism (2) previous allergy to ASPNN or its ingredients (3) inability to eat vegetables or spicy food (4) severe breastfeeding problems, such as abnormal breast anatomy, short nipples, mastitis, breast abscess and severe fetal tongue-tie (5) taking galactagogue, such as domperidone, metoclopramide, antidepressive drugs, caffeine and alcohol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| breast milk production on day 1 and day 3 after the intervention Volume by an electrical breastpump and a measuring flask | — |
Secondary
| Measure | Time frame |
|---|---|
| milk quality on day 1 and day 3 after the intervention cream percentage (creamatocrit) ,serum prolactin level on day 1 and day 3 after the intervention Prolactin II assay,safety of the intervention on day 3 observed unwanted effects | — |
Countries
Thailand
Contacts
Public ContactThapthep Thippayacharoentam
Center of Applied Thai Traditional Medicine, Faculty of Medicine Siriraj Hospital, Mahidol Universit
Outcome results
None listed